Detalhe da pesquisa
1.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645086
2.
Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.
Br J Haematol
; 180(3): 365-373, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29193021
3.
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only.
Oncologist
; 21(3): 279-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911408
4.
Sarcoid-like reaction in malignant melanoma exacerbated with pembrolizumab therapy case report.
Heliyon
; 10(2): e24375, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304765
5.
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
NPJ Breast Cancer
; 8(1): 117, 2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36333333
6.
The management of fatigue in cancer patients.
Oncology (Williston Park)
; 18(12): 1527-35; discussion 1536-8, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15609475